Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXON ENTERPRISE, INC.AXON · Entity 567 | Director | May 27, 2021 | June 01, 2021 |
| Better Therapeutics, Inc.BTTX · Entity 94385 | Director | December 18, 2023 | December 20, 2023 |
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2021 | January 04, 2022 |
| HERBALIFE LTD.HLF · Entity 4842 | Director | May 08, 2026 | May 13, 2026 |
| MCKESSON CORPMCK · Entity 2904 | Director | July 31, 2024 | August 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXON ENTERPRISE, INC.
Report date May 27, 2021 · Filed June 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,162 |
Reported balance
After 2021-05-27 transaction · row 1
1 source rowRow 1 · 2021-05-27 · Grant · Acquired 1,434 · Balance 19,162 F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 27, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 27, 2022.
Better Therapeutics, Inc.
Report date December 18, 2023 · Filed December 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 157,369 |
Reported balance
After 2023-12-18 transaction · row 1
1 source rowRow 1 · 2023-12-18 · Grant · Acquired 3,750 · Balance 157,369 F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
CLOROX CO /DE/
Report date December 31, 2021 · Filed January 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,007.9368 |
Reported balance
After 2021-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-02-12 · Grant · Acquired 136.5128 · Balance 23,007.9368 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,147.4855 |
Reported balance
After 2021-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-07 · Grant · Acquired 139.5487 · Balance 23,147.4855 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,306.8864 |
Reported balance
After 2021-08-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-08-13 · Grant · Acquired 159.4009 · Balance 23,306.8864 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,470.3051 |
Reported balance
After 2021-11-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-11-10 · Grant · Acquired 163.4187 · Balance 23,470.3051 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 24,388.9075 |
Reported balance
After 2021-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-31 · Grant · Acquired 918.6024 · Balance 24,388.9075 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
HERBALIFE LTD.
Report date May 08, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 83,645 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 11,879 · Balance 83,645 F1: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.
MCKESSON CORP
Report date July 31, 2024 · Filed August 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 349 |
Reported balance
After 2024-07-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-31 · Grant · Acquired 349 · Balance 349 F1: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board. |
Filing footnotes · ownership attribution and instrument terms
F1: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 963.0341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000382 · doc4.xml · derivative · entry 5 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,063.1529 Underlying: Common Stock · 963.0341 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 16, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 112.5053 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000382 · doc4.xml · derivative · entry 4 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100.1188 Underlying: Common Stock · 112.5053 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 00:53 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 1,000 | $61.72 | $61,720.00 |
DisclosureSEC source: 0001069183-18-000109 · wf-form4_154111999944135.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,647 F1 · kind: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2018 Stock Incentive Plan. The grant is scheduled to vest in one installment on October 31, 2019. Read SEC document |
| August 17, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 122.7565 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000382 · doc4.xml · derivative · entry 3 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,987.6135 Underlying: Common Stock · 122.7565 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 24, 2018 Filed May 24, 2018 22:42 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 2,577 | $62.08 | $159,980.16 |
DisclosureSEC source: 0001069183-18-000064 · wf-form4_152720170751512.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,647 Read SEC document |
| May 14, 2018 Filed May 15, 2018 16:00 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | Exercise / conversionDirector Stock Option · Derivative | 13,870 | $7.21 Strike: $7.21 | $100,002.70 |
DisclosureSEC source: 0001069183-18-000048 · wf-form4_152639994717989.xml · derivative · entry 2 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,870 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2018 Filed May 15, 2018 16:00 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | Exercise / conversionCommon Stock | 13,870 | $7.21 | $100,002.70 |
DisclosureSEC source: 0001069183-18-000048 · wf-form4_152639994717989.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 149.0557 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000382 · doc4.xml · derivative · entry 2 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,864.857 Underlying: Common Stock · 149.0557 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:08 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028910 · doc4.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,289 F1 · kind: Consists of restricted stock units ("RSU") under the Herbalife Nutrition Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Nutrition Ltd. common stock on vesting. This award will vest 100% on April 15, 2019. Read SEC document |
| February 09, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 121.2687 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000382 · doc4.xml · derivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,715.8013 Underlying: Common Stock · 121.2687 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,002.0689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000435 · doc4.xml · derivative · entry 5 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,594.5326 Underlying: Common Stock · 1,002.0689 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 13, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 108.7233 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000435 · doc4.xml · derivative · entry 4 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,592.4637 Underlying: Common Stock · 108.7233 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 04, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 108.5224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000435 · doc4.xml · derivative · entry 3 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,483.7404 Underlying: Common Stock · 108.5224 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:10 UTC | AXON ENTERPRISE, INC. AAXN · Entity 567 | GrantCommon Stock | 6,403 | $24.99 | $160,010.97 |
DisclosureSEC source: 0001069183-17-000096 · wf-form4_149582941445593.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,200 F1 · security: Time-vested restricted stock units granted to the reporting person pursuant to the TASER International, Inc. 2016 Stock Incentive Plan. The grant is scheduled to vest in three equal annual installments beginning on May 15, 2018. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031107 · doc4.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,094 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 05, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 103.9732 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000435 · doc4.xml · derivative · entry 2 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,375.218 Underlying: Common Stock · 103.9732 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:01 UTC | AXON ENTERPRISE, INC. TASR · Entity 567 | Exercise / conversionCommon Stock · Derivative | 19,405 | $22.49 Strike: $7.73 | $436,418.45 |
DisclosureSEC source: 0001069183-17-000048 · wf-form4_148901407004998.xml · derivative · entry 2 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,405 shares Expires 2017-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2017 Filed Mar 8, 2017 23:01 UTC | AXON ENTERPRISE, INC. TASR · Entity 567 | Exercise / conversionCommon Stock | 19,405 | $7.73 | $150,000.65 |
DisclosureSEC source: 0001069183-17-000048 · wf-form4_148901407004998.xml · nonDerivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 108.0888 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000435 · doc4.xml · derivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,271.2448 Underlying: Common Stock · 108.0888 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,136.5522 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000367 · doc4.xml · derivative · entry 5 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,163.156 Underlying: Common Stock · 1,136.5522 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 14, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 112.5266 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000367 · doc4.xml · derivative · entry 4 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,026.6038 Underlying: Common Stock · 112.5266 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 12, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 94.8537 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000367 · doc4.xml · derivative · entry 3 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,914.0772 Underlying: Common Stock · 94.8537 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 06, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 92.8203 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000367 · doc4.xml · derivative · entry 2 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,819.2235 Underlying: Common Stock · 92.8203 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 12, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 94.3756 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000367 · doc4.xml · derivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,726.4032 Underlying: Common Stock · 94.3756 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.